Blood cancers, High grade lymphoma, Non-Hodgkin lymphoma (NHL)
Results
Phase 3
This trial looked at obinutuzumab and CHOP chemotherapy for diffuse large B cell lymphoma (DLBCL).
It was for people having their first treatment for DLBCL.
The trial was open for people to join between 2011 and 2014. The team published the results in 2020.
Recruitment start: 20 October 2011
Recruitment end: 5 June 2014
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Martin Dyer
Experimental Cancer Medicine Centre (ECMC)
Genentech Ltd
Roche
Last reviewed: 13 Mar 2024
CRUK internal database number: 9357
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
